PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
65.37%
Cash & equivalents growing 65.37% while MCHP's declined -25.72%. Peter Lynch would see this as a sign of superior liquidity management.
-23.00%
Both MCHP and the company show zero Short-Term Investments Growth.
-1.78%
Below half of MCHP's -25.72%. Michael Burry might suspect a liquidity shortfall if there's no alternative capital plan.
7.14%
Receivables growth above 1.5x MCHP's 3.01%. Michael Burry would check for potential credit bubble or inflated top-line.
7.55%
Inventory growth above 1.5x MCHP's 4.55%. Michael Burry might suspect a looming inventory glut. Check free cash flow impact.
-2.38%
Other current assets growth < half of MCHP's 4.75%. David Dodd sees a leaner approach to short-term items.
2.52%
Below half of MCHP's -0.70%. Michael Burry could suspect a liquidity squeeze. Verify operational performance.
-1.39%
1.25-1.5x MCHP's -1.16%. Bruce Berkowitz notes a significant push to expand capacity faster than competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-8.70%
Higher Tax Assets Growth compared to MCHP's zero value, indicating worse performance.
-6.91%
Above 1.5x MCHP's -1.17%. Michael Burry warns of potential hidden liabilities or intangible bloat.
-4.01%
≥ 1.5x MCHP's -1.16%. David Dodd sees significantly higher long-term asset buildup. Confirm synergy with strategy.
No Data
No Data available this quarter, please select a different quarter.
-1.20%
1.25-1.5x MCHP's -0.99%. Bruce Berkowitz sees a stronger asset build. Check if it's producing returns.
-66.69%
Above 1.5x MCHP's -19.35%. Michael Burry questions if payables are being stretched to avoid short-term borrowing.
-2.62%
Less than half of MCHP's -18.76%. David Dodd sees much smaller short-term leverage burden vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Below half of MCHP's 16.99%. Michael Burry suspects a big gap in pre-sales traction.
-100.00%
Exceeding 1.5x MCHP's -0.41%. Michael Burry suspects ballooning short-term obligations vs. competitor.
-6.97%
Above 1.5x MCHP's -1.32%. Michael Burry sees a red flag for liquidity risk vs. competitor.
-3.70%
Less than half of MCHP's 429.28%. David Dodd sees more deleveraging vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
-7.09%
Less than half of MCHP's 6.12%. David Dodd sees fewer additions to deferred tax liabilities vs. competitor.
-6.17%
Less than half of MCHP's 42.60%. David Dodd notes more conservative expansions in non-current obligations.
-5.30%
Less than half of MCHP's 210.63%. David Dodd sees a more conservative approach to non-current liabilities.
No Data
No Data available this quarter, please select a different quarter.
-6.08%
Less than half of MCHP's 22.94%. David Dodd sees far fewer liability expansions relative to competitor.
0.26%
Higher Common Stock (Book Value) Growth compared to MCHP's zero value, indicating worse performance.
4.17%
0.5-0.75x MCHP's 5.96%. Martin Whitman is wary of weaker retention or lower profitability.
3.38%
Less than half of MCHP's -9.31%. David Dodd sees fewer intangible or market-driven swings than competitor.
100.00%
Less than half of MCHP's -100.00%. David Dodd notes simpler yoy equity changes vs. competitor.
2.33%
Below half MCHP's -11.25%. Michael Burry sees potential underperformance in building shareholder capital.
-1.20%
1.25-1.5x MCHP's -0.99%. Bruce Berkowitz checks if expansions are well-justified by ROI.
-23.00%
Both MCHP and the company show zero Total Investments Growth.
-3.48%
Less than half of MCHP's 115.31%. David Dodd sees less overall debt expansion vs. competitor.
-52.79%
Less than half of MCHP's 1388.83%. David Dodd sees better deleveraging or stronger cash buildup than competitor.